#NovoNordisk #Novo #weightloss #obesity #diabetes #TheNovoWay #GLP1agonists #semaglutide #Wegovy #Ozempic #oralWegovy #clinicaltrials #IL6inhibitor #ziltivekimab #heartfailure #atherosclerosis #CagriSema #cagrilintide #patentcliff #corporateculture #LastingHealthStartsNow
zurl.co/oizn3

#NovoNordisk has opted to discontinue two late-stage trials of IL-6 inhibitor #ziltivekimab in #heartfailure, after an interim look at the data suggested they would be unlikely to show a positive result.

pharmaphorum.com/news/novo-no...

💉 #pharma

Novo's #ziltivekimab cut the inflammation marker 88% in phase 2. That is why it went into a 6,300-patient phase 3.

Heart attacks, strokes and CV deaths: 0.99. No change at all.

midgardfinance.com/companies/NOVO-B.CO/

🇩🇰 $NOVO